Research and Markets: Hyperlipidemia Drug Pipeline Update 2014-2017
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/98fcxg/hyperlipidemia) has announced the addition of the "Hyperlipidemia Pipeline Highlights - 2014 Update" report to their offering.
The latest report Hyperlipidemia Pipeline Highlights - 2014 Update, provides most up-to-date information on key pipeline molecules in the global Hyperlipidemia market. It covers emerging therapies for Hyperlipidemia in active clinical development stages including early and late stage clinical trials.
The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Key Topics Covered:
1. Hyperlipidemia Pipeline by Stages
2. Hyperlipidemia Pipeline by Drug Class
3. Hyperlipidemia Pipeline by Company
4. Hyperlipidemia Phase 3 Clinical Trial Insights
5. Hyperlipidemia Phase 2 Clinical Trial Insights
6. Hyperlipidemia Phase 1 Clinical Trial Insights
7. Hyperlipidemia Preclinical Research Insights
8. Hyperlipidemia Discovery Stage Insights
For more information visit http://www.researchandmarkets.com/research/98fcxg/hyperlipidemia